Clinical Trials Directory

Trials / Conditions / Advanced or Metastatic NSCLC

Advanced or Metastatic NSCLC

7 registered clinical trials studyying Advanced or Metastatic NSCLC — 1 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingA Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years Wit
NCT05941897
AstraZenecaPhase 2
RecruitingPhase 1/2 Study of HS-10375 in Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)
NCT05435248
Jiangsu Hansoh Pharmaceutical Co., Ltd.Phase 1 / Phase 2
UnknownPK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemother
NCT04942301
Jiangsu Simcere Pharmaceutical Co., Ltd.Phase 1
Active Not RecruitingPhase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metast
NCT04612751
AstraZenecaPhase 1
Active Not RecruitingDatopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in S
NCT04526691
Daiichi SankyoPhase 1
CompletedA PK Similarity Study of Two Sintilimab Products Produced by Different Processes in Advanced or Metastatic NSC
NCT04177290
Innovent Biologics (Suzhou) Co. Ltd.Phase 1
TerminatedElderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies
NCT03673332
Institut Paoli-CalmettesPhase 4